Bristows' Podcast
Never content to do the bare minimum, we've always been at the forefront of change. You could say we are and always have been a bit different from other law firms. Our legal expertise joined up with our science and technology backgrounds means we understand your business and can talk the same language. And that's essentially what we cover in this podcast. A truly independent approach to litigation, transactions and advice throughout the world.
Bristows' Podcast
Biotech Review of the Year: Six months on
It's hard to believe that six months have passed since we released the 11th edition of our Biotech Review of the Year publication.
Our editors, Greg Bacon, Xisca Borrás, and Will Hewitt, thought now would be a great time to catch up and discuss any developments since the launch.
You can also find written updates on the following articles here:
- Integrating generative AI into the life science ecosystem – five tips for success
- Revision of the EU pharmaceutical law regime – what does it mean for biotech companies?
- The first 12 months of the Unified Patent Court
- The application of G2/21 by the Court of Appeal
- Strategic considerations for partnering with CDMOs for cell and gene therapies
- Biotech settlement agreements – a competition law checklist